Chrissy Metz Opens Up About Embracing GLP-1 Treatment for Weight Loss Journey

In an exclusive interview with People, actress Chrissy Metz, 45, known for her role in "This Is Us," has shared her decision to take GLP-1 medication as part of her ongoing weight loss journey. After years of unsuccessful dieting and battling obesity within her family, the star felt it was time to explore new options. "I'm not getting any younger," Metz admitted. "I've tried countless diets and therapies, but nothing really worked for me. I wanted a sustainable solution that would help me manage my weight effectively." Metz has partnered with Ro, a direct-to-patient digital health company providing GLP-1 treatments. She is yet to disclose the specific type of medication or when she started taking it, but her experience so far has been positive. "The change has been great," Metz said. "I'm no longer fixated on every bite I take. It's a relief not to be constantly worried about my food choices, even as I'm still working on building muscle with my trainer." Addressing potential criticism, the actress remains unfazed. "There will always be people who have something to say, but they don't matter," she asserted. "They're not a part of my life or my health journey." Chrissy Metz emphasized that her primary focus is self-care and wellbeing. She acknowledged the importance of destigmatizing weight loss treatments like GLP-1, but also highlighted that personal choices are crucial for each individual's body and health. "Ultimately, we all just want to feel good about ourselves," Metz said. "I'm simply a regular woman who is trying her best." In 2025, Metz revealed to the Daily Mail that she had lost 100 pounds through strength training. When asked about Ozempic at the time, she expressed openness to discussing weight loss treatments but reiterated that personal decisions regarding one's body are paramount. Metz continues to work closely with her trainer and hasn't set specific weight loss goals. "I'm just focused on taking care of myself and feeling good," she emphasized. "That's what truly matters."